Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
University of Pittsburgh
Bolt Biotherapeutics, Inc.
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
Vyriad, Inc.
Jules Bordet Institute